UPDATE: Rubius (RUBY) PT Lowered to $4 at Morgan Stanley on Disappointing RTX-240 Monotherapy Data
Tweet Send to a Friend
(Updated - April 11, 2022 7:29 AM EDT)
Morgan Stanley analyst Jeffrey Hung lowered the price target on Rubius ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Jeffrey Hung lowered the price target on Rubius ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
